 Home > Active Pharmaceutical Ingredients > Digestive System Drugs > Vonoprazan fumarate for Sale > Vonoprazan Fumarate 98% white powder Xieli with CAS 1260141-27-2

Vonoprazan Fumarate 98% white powder Xieli with CAS 1260141-27-2

Name: Vonoprazan Fumarate 98% white powder Xieli with CAS 1260141-27-2
Brand: Xieli
SKU: pr2203011346
Price: 8 USD
Availability: InStock

1 Inquiries

Unit Price: Get Latest Price 

CAS No.:

1260141-27-2

Grade:

Pharmaceutical Grade

Content:

98%

Brand:

Xieli

Packaging:

according to customer requirement

Sample Available:

Yes

Price valid (until):

2023-10-07

Contact Supplier

 Chat Now

sichuan xieli pharmaceutical co., ltd

Company Type:

Manufactory

Location:

China

Payment Terms:

TT against copy of documents,L/C

Average Lead Time:

15 days

Qualification:

Main Products:

dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

 Visit Store

Product Details
Seller Information
Inquiry History

Description

Items	Specifications
Appearance	white powder
Molcular Formula	C17H16FN3O2S·C4H4O4
CAS	1260141-27-2

Introduction of Vonoprazan Fumarate

Vonoprazan Fumarate was deveoped by Takeda Pharmaceutical Company Limited to treat reflux esophagitis and came into the Chinese market in 2019.

About us

Xieli Pharm was Founded in 1980's as professional manufacturer on oncology& Animal/botanical derivative APIs and CMO services, with cGMP\ EU GMP\ Japan GMP certified factory and independent R& D center. R& D team with rich experience in process development in R& D, process scale-up and production, and succeed to finish many CMO projects. RA team with rich experience for global registration. DMF including 17 products registered in 100+ countries and submission 500+ times. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin & Troxerutin& Irinotecan HCl& Gefitinib& Anastrozole. OEM for plant extracting and TCM Processing. CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.

ECHEMI Editorial Reference

TAK-438 is an orally active potassium-competitive acid blocker which inhibits H+, K+-ATPase activity with an IC50 of 19 nM.
Vonoprazan fumarate (Takecab), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer, duodenal ulcer and reflux esophagitis.

Basic Info

Product Name:

Vonoprazan fumarate

Other Name:

1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine;AK-438;Vonaprazan(TAK-438);vonoprazan(tak-438);vonoprazan(tak-438)1260141-27-2;fuMarate vonoprazan;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate TAK 438;vonaprazan(TK-438)

CAS No.:

1260141-27-2

Molecular Formula:

C21H20FN3O6S

InChIKeys:

ROGSHYHKHPCCJW-WLHGVMLRSA-N

Molecular Weight:

461.4634032

Exact Mass:

461.105682

EC Number:

250-635-4

Categories:

Digestive System Drugs

Characteristics

PSA:

147

XLogP3:

3.82910

Critical Temperature & Pressure:

Store at -20°C

Hazard Identification

Classification of the substance or mixture

no data available

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)	no data available
Signal word	no data available
Hazard statement(s)	no data available
Prevention	no data available
Response	no data available
Storage	no data available
Disposal	no data available

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Vonoprazan fumarate Safety Data Sheet 

Seller Information

Business Type:
Manufactory

Main Products:
dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

Location:
NO.588, middle section of mudan avenue

Payment Terms:
TT against copy of documents,L/C

Average lead Time:
15 days

Total Annual Revenue:
Above $100 million

Total Employees:
501-1000

Year of Establishment:
1992

Company Profile
Xieli Pharm was founded in 1980's with cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin and Troxerutin OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.

Inquiry History

1 Inquiries

Country	Product	Purchase Quantity	Date Posted
Egypt	Vonoprazan Fumarate	3 KG	Jul 29, 2024

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
99.0% Vonoprazan Fumarate	Pharmaceutical Grade/99	$1111-1222/KG FOB	Chong Da Prostaglandin Fine Chemicals Co., Ltd	Inquiry
Vonoprazan fumarate RC05678	Pharmaceutical Grade/99	$1/KG EXW	Hangzhou Royalchem Co.,LTD	Inquiry
Vonoprazan fumarate Factory Direct Supply High Quality 99% Purity Vonoprazan fumarate CAS No.: 1260141-27-2	Pharmaceutical Grade/99		HNB Biotech	Inquiry
Vonoprazan fumarate 1260141-27-2	Pharmaceutical Grade/99		Hainan Flying International Trade Co., L	Inquiry
Factory Direct Supply High Quality TNJONE 99% Purity Vonoprazan fumarate 1260141-27-2	Top Product/99		Shaanxi TNJONE Pharmaceutical Co., Ltd	Inquiry

Vonoprazan Fumarate 98% white powder Xieli with CAS 1260141-27-2

Product Details

Seller Information